72 related articles for article (PubMed ID: 11805153)
1. Impaired migration of IgA-secreting cells to colon adenocarcinomas.
Muthuswamy RV; Sundström P; Börjesson L; Gustavsson B; Quiding-Järbrink M
Cancer Immunol Immunother; 2013 Jun; 62(6):989-97. PubMed ID: 23591979
[TBL] [Abstract][Full Text] [Related]
2. An mRNA-based platform for the delivery of pathogen-specific IgA into mucosal secretions.
Deal CE; Richards AF; Yeung T; Maron MJ; Wang Z; Lai YT; Fritz BR; Himansu S; Narayanan E; Liu D; Koleva R; Licht S; Hsiao CJ; Rajlic IL; Koch H; Kleyman M; Pulse ME; Weiss WJ; Doering JE; Lindberg SK; Mantis NJ; Carfi A; Plante OJ
Cell Rep Med; 2023 Nov; 4(11):101253. PubMed ID: 37918405
[TBL] [Abstract][Full Text] [Related]
3. CCL28 Is Involved in Mucosal IgA Responses, Olfaction, and Resistance to Enteric Infections.
Burkhardt AM; Perez-Lopez A; Ushach I; Catalan-Dibene J; Nuccio SP; Chung LK; Hernandez-Ruiz M; Carnevale C; Raffatellu M; Zlotnik A
J Interferon Cytokine Res; 2019 Apr; 39(4):214-223. PubMed ID: 30855201
[TBL] [Abstract][Full Text] [Related]
4. Defensive Driving: Directing HIV-1 Vaccine-Induced Humoral Immunity to the Mucosa with Chemokine Adjuvants.
Gary EN; Kutzler MA
J Immunol Res; 2018; 2018():3734207. PubMed ID: 30648120
[TBL] [Abstract][Full Text] [Related]
5. Role of Natural Autoantibodies and Natural IgM Anti-Leucocyte Autoantibodies in Health and Disease.
Lobo PI
Front Immunol; 2016; 7():198. PubMed ID: 27375614
[TBL] [Abstract][Full Text] [Related]
6. CCL28 is increased in human Helicobacter pylori-induced gastritis and mediates recruitment of gastric immunoglobulin A-secreting cells.
Hansson M; Hermansson M; Svensson H; Elfvin A; Hansson LE; Johnsson E; Sjöling A; Quiding-Järbrink M
Infect Immun; 2008 Jul; 76(7):3304-11. PubMed ID: 18426876
[TBL] [Abstract][Full Text] [Related]
7. CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells.
Kunkel EJ; Kim CH; Lazarus NH; Vierra MA; Soler D; Bowman EP; Butcher EC
J Clin Invest; 2003 Apr; 111(7):1001-10. PubMed ID: 12671049
[TBL] [Abstract][Full Text] [Related]
8. The preference for switching to expression of the IgA isotype of antibody exhibited by B lymphocytes in Peyer's patches is likely due to intrinsic properties of their microenvironment.
Cebra JJ; Logan AC; Weinstein PD
Immunol Res; 1991; 10(3-4):393-5. PubMed ID: 1955763
[No Abstract] [Full Text] [Related]
9. Evolution, development, mechanism and function of IgA in the gut.
Fagarasan S
Curr Opin Immunol; 2008 Apr; 20(2):170-7. PubMed ID: 18456485
[TBL] [Abstract][Full Text] [Related]
10. The intestinal chemokine thymus-expressed chemokine (CCL25) attracts IgA antibody-secreting cells.
Bowman EP; Kuklin NA; Youngman KR; Lazarus NH; Kunkel EJ; Pan J; Greenberg HB; Butcher EC
J Exp Med; 2002 Jan; 195(2):269-75. PubMed ID: 11805153
[TBL] [Abstract][Full Text] [Related]
11. Differentiated B lymphocytes. Potential to express particular antibody variable and constant regions depends on site of lymphoid tissue and antigen load.
Gearhart PJ; Cebra JJ
J Exp Med; 1979 Jan; 149(1):216-27. PubMed ID: 105075
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen.
Stanisz AM; Befus D; Bienenstock J
J Immunol; 1986 Jan; 136(1):152-6. PubMed ID: 2415614
[TBL] [Abstract][Full Text] [Related]
13. A common mucosal chemokine (mucosae-associated epithelial chemokine/CCL28) selectively attracts IgA plasmablasts.
Lazarus NH; Kunkel EJ; Johnston B; Wilson E; Youngman KR; Butcher EC
J Immunol; 2003 Apr; 170(7):3799-805. PubMed ID: 12646646
[TBL] [Abstract][Full Text] [Related]
14. CC chemokine ligands 25 and 28 play essential roles in intestinal extravasation of IgA antibody-secreting cells.
Hieshima K; Kawasaki Y; Hanamoto H; Nakayama T; Nagakubo D; Kanamaru A; Yoshie O
J Immunol; 2004 Sep; 173(6):3668-75. PubMed ID: 15356112
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]